| A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients (NCT00001669) | National Institute of Neurological Disorders and Stroke (NINDS) | 1997-07-01 |
| Prescription Drug Safety and Effectiveness in Multiple Sclerosis (NCT04472975) | University of British Columbia | 1996-01-01 |
| NARCOMS Registry: A Multiple Sclerosis Registry (NCT01018537) | University of Texas Southwestern Medical Center | 1996-01-01 |
| A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis (NCT00004816) | National Center for Research Resources (NCRR) | 1995-07-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis (NCT00004744) | National Institute of Neurological Disorders and Stroke (NINDS) | 1993-02-01 |
| Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS) (NCT00001248) | National Institute of Neurological Disorders and Stroke (NINDS) | 1992-07-23 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis (NCT00004814) | National Center for Research Resources (NCRR) | 1991-10-01 |
| Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis (NCT01226654) | NYU Langone Health | 1991-08-01 |
| Optic Neuritis Treatment Trial (ONTT) (NCT00000146) | National Eye Institute (NEI) | 1988-07-01 |
| Longitudinal Optic Neuritis Study (LONS) (NCT00000147) | National Eye Institute (NEI) | 1988-07-01 |
| Assessment of Patients With Multiple Sclerosis (MS) (NCT00001156) | National Institute of Neurological Disorders and Stroke (NINDS) | 1976-01-23 |
| Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis. (NCT01868048) | GW Research Ltd | |
| Sleep Disorders in Patients With Multiple Sclerosis (NCT00137904) | Groupe Hospitalier Pitie-Salpetriere | |
| Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS) (NCT00313976) | Bayer | |
| Intermediate Expanded Access Protocol CNMAu8.EAP03 (NCT04081714) | Clene Nanomedicine | |
| Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis (NCT03822858) | Tisch Multiple Sclerosis Research Center of New York | |
| Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron) (NCT00439257) | US Department of Veterans Affairs | |
| Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease (NCT04540861) | Novartis Pharmaceuticals | |
| Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up (NCT00289159) | Groupe Hospitalier Pitie-Salpetriere | |
| Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis (NCT02807285) | Genentech, Inc. | |
| Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis (NCT00043264) | National Center for Research Resources (NCRR) | |
| A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis (NCT02317263) | University of California, Los Angeles | |
| Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies (NCT01020370) | Wayne State University | |
| Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple Sclerosis (NCT02896933) | Fondation Ophtalmologique Adolphe de Rothschild | |